Shares of Marubeni Co. (OTCMKTS:MARUY – Get Rating) hit a new 52-week high during trading on Wednesday . The company traded as high as $123.02 and last traded at $122.91, with a volume of 4653 shares traded. The stock had previously closed at $122.67.
Marubeni Stock Up 0.2 %
The company has a debt-to-equity ratio of 0.58, a current ratio of 1.25 and a quick ratio of 0.98. The company has a market cap of $21.12 billion, a price-to-earnings ratio of 4.90, a P/E/G ratio of 0.59 and a beta of 0.91. The firm’s 50 day simple moving average is $113.82 and its 200-day simple moving average is $101.64.
Marubeni (OTCMKTS:MARUY – Get Rating) last released its quarterly earnings results on Friday, November 4th. The conglomerate reported $4.75 EPS for the quarter. Marubeni had a net margin of 5.32% and a return on equity of 21.05%. The business had revenue of $19.45 billion for the quarter. As a group, sell-side analysts anticipate that Marubeni Co. will post 24.27 earnings per share for the current year.
About Marubeni
Marubeni Corp. engages in the business of importing and exporting services. It operates through the following segments: Food & Consumer Products; Chemical & Forest Products; Energy & Metals; Transportation & Industrial Machinery; Power Projects & Plant; and Others. The Food & Consumer Products segment engages in the manufacture and trade of all food products including feed grains, soybeans, wheat, sugar, processed foods, beverages, and their raw materials, foodstuffs for professional use, and agricultural, seafood and livestock products.
Further Reading
- Get a free copy of the StockNews.com research report on Marubeni (MARUY)
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Receive News & Ratings for Marubeni Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marubeni and related companies with MarketBeat.com's FREE daily email newsletter.